The US Approved an Alzheimer’s Drug. Seven Patients Subsequently Died
April 1, 2025

(Bloomberg via MSN) – Aaron is one of at least seven people who have died in the US from symptoms linked to the drug Leqembi over the past two years, according to a Bloomberg review of federal records obtained through the Freedom of Information Act. Three others have suffered lasting disabilities, according to these FDA reports. Each case Bloomberg counted was based on detailed adverse event reports that specifically mentioned brain swelling or bleeding, possible side effects of Leqembi that were controversial at the time of the drug’s approval. (Read More)